Medical Journalism

Terra Sigillata

Category archives for Medical Journalism

NIH has just announced the acceptance of applications for their 7th annual conference, Medicine in the Media: The Challenge of Reporting on Medical Research, 5-7 May, 2008. The National Institutes of Health’s Office of Medical Applications of Research (OMAR) presents a free annual training opportunity to help develop journalists’ ability to evaluate and report on…

The genetics of autism

I don’t often venture into the fray whereby the misinformed continue to insist that thimerosal-containing vaccines cause autistic spectrum disorders when all evidence to date has led the scientific community to reject this hypothesis. However, recent stories on celebrities, namely Jenny McCarthy and Donald Trump, spouting forth about vaccines and autism led me to read…

Second anniversary of Terra Sigillata

On this day in 2005 we first signed on to the blogosphere on the original Terra Sigillata at Blogger. I had spent over six months reading the blogs of other in the areas of medicine and science and wondered if there was any need for yet another blog from another frustrated scientist. But I’m an…

I’m happy to report that physician-journalist, Tom Linden, MD, has begun blogging over at Dr Mike Magee’s Health Commentary. Dr Linden is currently Glaxo Wellcome Distinguished Professor of Medical Journalism and director of the Medical Journalism Program at the University of North Carolina at Chapel Hill J-school. As an example of the visibility of the…

We’ve been speaking about this issue on behalf of our lymphoma colleagues since late August. But yesterday’s New York Times (Alex Berenson) and Wall Street Journal’s Health Blog (Jacob Goldstein) brought greater awareness to the issue of Medicare’s proposal to cut reimbursement for “smart-bomb” radioimmunotherapies for lymphomas. So far, it appears that Medicare will move…

I can’t do any better than this today: I finally got around to reading yesterday’s Cancer Research Blog Carnival that I cited and was completely entranced by Matthew Zachary’s essay in The Huffington Post about his long battle with medulloblastoma. It was posted originally in July and provides outstanding insights on the life of a…

…is the title of a Newsweek article by Jonathan Alter posted online last night that draws more attention to the Medicare restriction on reimbursements for radioimmunotherapeutic (RIT) drugs used to treat lymphomas. Surgical oncologist, Orac, and I have spoken about this issue in the last few days. Alter admits his bias a bit, as he…

Via the Knight Science Journalism Tracker at MIT, I was directed to one of the best-written articles on melamine contamination of pet food and animal feed. David Brown at the Washington Post is the guilty party whose article appeared Monday. Brown does a terrific job of explaining how the modestly toxic substance, melamine, can cause…

Perversion of good science

More Canadian press leads me to put up another post on dichloroacetate (DCA), the inhibitor of mitochondrial aerobic glycolysis that is being promoted as a freely-available cancer “cure.” Like many compounds tested in animal models of human cancer, DCA treatment reduces the size of human lung tumors grown in rats, but is far from a…

My blog buddy Orac at Respectful Insolence has a superb post today following up on his continuous coverage of dichloroacetate and two posts I had recently on local coverage in the Edmonton Journal of this unapproved, experimental compound. As an oncologic surgeon, he provides an authoritative rebuttal to the argument that there’s no harm in…